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Treatment Overview
There is a paucity of data about use of HBOT in veterinary 
medicine, and no randomized, controlled clinical trials for any 
condition have been published. Thus, veterinarians must rely 
on the comparatively more robust human literature. 
There are currently 48 Hyperbaric Veterinary Chambers in 
the United States in both private and university hospitals.
Current Monoplace Veterinary 
Chamber
Small animal monoplace chamber (exact standards as a human chamber 
or a human chamber).  Can fit in the space where our washer and dryer 
were previously located.
Oxygen supply can 
be simple
• We use 
containers 
called Dewars
and a back up 
K tank
• Simple use, not 
bad expense, 
small footprint.
• Our space is 
VERY limited 





Effects from Direct Pressure in HBOT
• At 2.8 atmospheres, any bubble volume reduces by almost two thirds.
• Dissolution of gas in solution prevents the formation of new bubbles.
• An inert-gas bubble will easily dissolve in 100% O2 by replacing the inert 
(nitrogen) gas 
in the bubble with oxygen, which is then rapidly metabolized by the tissues. 
Compression in a chamber will decrease gas from
 ileus
 bloat or severe intraluminal gas accumulation. 
 useful in perioperative gastrointestinal obstruction
 gas gangrene
 emphysematous biliary or urinary bladder tissues
 Subcutaneous emphysema
Due to:
• Reduction in gas volume
• Nitrogen, hydrogen, methane and CO2 diffusion into tissues and blood 
• High gradient for gas removal via respiration 
• The decrease in pressure from gas in tissues or cavities results in less 
injury from vascular compromise, decreased bacterial translocation, 
necrosis, pain and swelling.
Hyper-Oxygenation
Besides bringing oxygen to damaged tissues in a high concentration….
• Tissues become more dense from pressure creating a larger overlap of 
oxygen rich tissues
• Oxygen tensions remain elevated up to 4 hours after therapy, results last 
longer
Oxygen induces vasoconstriction without causing hypoxia
• Oxygen induces smooth muscle contraction in all muscularized vessels 
(arterial and venous) not capillaries or lymphatics
• This decreases bleeding/oozing from vessels  
• Several animal models of hyperoxic vasoconstriction suggest that
O2 tension may influence one or more of the endothelium-derived factors, 
such as NO, endothelin, and vasoactive PG.
• It has been demonstrated that both hyperoxia and oxidative stress may 
stimulate increased production of the endothelium-derived vasoconstrictor 
endothelin.
Reduction of swelling and edema
• HBOT decreases filtration of fluid from the capillary to the 
extracellular space due to vasoconstriction while 
reabsorption of fluid at the capillary level and into 
lymphatics is maintained. Enhanced diffusion of fluid into 
lymphatics and capillaries.
• Reducing edema decreases capillary diffusion distances, 
increasing oxygen perfusion. 
• Fluid reabsorption helps inflammatory cells remove cell debris 
and micro-organisms
The decrease in pressure from edema reduction results in 
less injury from vascular compromise, decreased bacterial 
translocation, necrosis, pain and swelling.
Hyper-Oxygenation
Immediate post-op debridement of necrotic pancreatic tissue; 
had reaction to plasma transfusion. No steroids given.
Effects of HBOT are prolonged. Gas and tissue levels of O2 decrease 
rapidly after HBOT, but are still elevated for at least 4 hours. Many 
effects last much longer.
The decrease in pressure from reduction of gas in 
tissues or cavities and reduction of edema results in 
less injury from vascular compromise, decreased 
bacterial translocation, necrosis, pain and swelling. 
Dayenu נּו יֵּ דַּ
Diane’s Mantra for hyperbaric oxygen therapy
 Reduction of reactive oxygen species  
 Decreased inflammation- decreases likelihood
 of thrombosis by protection of microcirculation
- Significant rapid decrease in discomfort
- Reduced time to eating again and hospitalization
- Reduction in pancreatic edema/size on ultrasound
- Treat for 1-3 days unless severe necrotizing pancreatitis
Urinating blood, 
Lethargic 6/2/17, DIC, 
Hyperthermia causing 
necrotizing pancreatitis 
with septic peritonitis 
and multiple organ 
failure (kidneys, liver) 
E.coli 4+ (abdomen)
Treatment: ICU, Fresh 
frozen plasma, 
PRP,Hetastarch, IV 
Unasyn and Baytril, 




Released Home!! 5 DAYS!!
All biochemical 
abnormalities – nearly 
normal
Clotting factors – normal
HBOT 5 sessions
6/2,6/3,6/3,6/4,6/5
3 yr MN DSH
June 16, 2017
5 day history of vomiting and 
anorexia, severe dehydration 
and seizures 
Intestinal perforations with septic 
peritonitis . Four enterotomies and 21 
perforation repairs. Patient began HBOT 












Severe pain, swelling, induration, poorly defined 
margins, fever, severe necrosis and sloughing of tissues.
Mantra: The decrease in pressure from reduction of gas in tissues or 
cavities and reduction of edema results in less injury from vascular 
compromise, decreased bacterial translocation, necrosis, pain and 
swelling.  
Pasturella- facultative 
anaerobe. Dead tissue: 
Great place for bacteria 
to flourish.
With HBOT
• Edema reduced 50%.
• Marked reduction in 
swelling. 
• Fever resolved.
• Tissue necrosis 
stabilized, margins are 
defined.
• Increased blood flow 
and O2 to tissues.


















October 31, 2015  BDLD
“Charlie Brown” Thompson 
6 yr MI Dachshund Mix
November 9, 2015
“Charlie Brown” Thompson 
He received 
daily  HBOT 













November 13, 2015 November 23, 2015









HBOT Immediately Post-Op 
1.5 ATA 30 min.
HBOT  Daily 1.5 ATA 30 min 
combine with LASER Therapy
July 27, 2017 July 31, 2017 (Presented July 18) 
Episode of acute onset forelimb paresis occurred night before. 
Blood pressure: >260 systolic. Petechial hemorrhages in retina pre-
treatment.
After diagnosis, 1 hour post first dose of amlodipine. This video is 
immediate post first treatment with HBOT.  1 hour, 1.5 ATA
Episode occurred 4 nights prior; 1st tx was 3 days ago (Friday), 
2nd  tx, 2 days ago (Sat), 3rd tx today (Monday). Each treatment:  
1 hour at 1.5 ATA.











•Oomycetes organism found 
throughout the south
•Closely related to algae, diatoms and 
seaweed.
•Antifungals and antibiotics largely 
ineffective
•Subcutaneous and gastrointestinal 
forms causing severe locally invasive 
granulomatous/eosinophilic
masses
•Significant morbidity and mortality
Treatment Options:
•Wide surgical resection if 
possible
•Minocycline
•Mefenoxam (herbacide used to 
treat crops)
•Prednisone
•HBOT 3 sessions week 1, 2 




•Minocycline 10 mg/kg PO SID x 2 
months
•Mefenoxam 8 mg/kg PO SID x 3 
months
•Prednisone 1 mg/kg PO SID x 1 
month
•HBOT 1.5 ATA 30 min 17 sessions
3 x per week (weeks 1 & 2)
2 x per week (weeks 3,4,5,6)




Feb. 23, 2017 Seroconverted – Negative
No clinical signs or US findings of disease.
Clinical Case: Cutaneous
Pythium
Images Copyright Shmalberg / University of Florida
 Oncology:
• Post-operative healing
• Pre and post radiation therapy
• Palliative care for neoplasia, pain and swelling
• Radiation burns/necrosis
• Osteoradionecrosis
• Soft tissue radionecrosis
• Doxorubicin extravasation
• Metabolic Therapeutics
Effects of doxorubicin extravasation
in humans
Only treatments are dexrazoxane (Zinecard), sargramostim, and hyperbaric 
oxygen for doxorubicin extravasations. 
Human chest (had 
port)
Ein Nichols   lymphoma:  Jan 17th 2013 got Adriamycin
• Jan 17: got Dexrazoxane-
10 times adriamycin
dose
• Jan 18: got Dexrazoxane-
5 times Adriamycin dose
• Jan 28 one treatment with 
HBOT
• Seemed better but 
worsened over next 30 
days
• Started BID HBOT on 3/5 
(7 weeks later)
The day we began: 7 weeks post chemo
Day 3     6  Treatments                  Day 6   11 treatments
Day 1
He wore his nails from knuckling due to nerve entrapment/ compartment 
syndrome. Knuckling has stopped.
Day 24  treatment 29                                 Day 25  treatment  32
Treatment 40
All better   Day 52       treatment 46
Still some 
induration in the 
armpit but no pain
Day 34       treatment 37
More of Ein- with HBOT: We switched to mitoxantrone instead of 
doxorubicin     Survived 22 months after diagnosed with LSA 
 Envenomation- Brown 
Recluse Spider




Day 2Day 1 Day 3
A trio of dogs attacked a 5 
foot Canebrake rattlesnake. 
The snake fought back. All 
three presented with 
neurological signs and this 
one also had bad soft tissue 
swelling. These snakes have 
both a neurotoxin, 
hemotoxin and myotoxin
that case severe tissue 
necrosis, sloughing, DIC and 
death.
Peter Brofman, DVM, MS, ACVIM (neurology and 
internal medicine)
Veterinary Specialty Care South Carolina
Day 1
Day 2
Peter Brofman, DVM, MS, ACVIM (neurology and 
internal medicine)
Veterinary Specialty Care South Carolina
Peter Brofman, DVM, MS, ACVIM 
(neurology and internal medicine)
Veterinary Specialty Care     South Carolina
 Left untreated they will 
continue to swell 
severely likely causing 
airway obstruction and 
severe necrosis in other 
swollen areas. The 






• Acute Renal Failure
• Possible PLN in 
conjunction with 
therapy for underlying 
disease
• Lyme nephritis
Inflammatory, infectious and immune 
mediates diseases




• RMSF induced 
vasculitis/ 
meningitis/arthritis 
• Immune mediated 
polyarthritis










• Anaerobic infections: 
• Actinomyces,clostridium
(gas gangrene), etc
• Intracranial and 
abdominal abscess
12/9 12/11 12/12 12/13 12/14 12/15 12/16
BUN 
(9.0-29.0)
18.1 83.2 131.2 123.8 77.1 52.9 42.5
Cr
(0.4-1.4)
0.9 6.7 8.6 8.0 3.6 3.6 1.9
Phos
(1.9-5.0)
2.8 6.1 10.2 10.0 6.7 5.9 5.0
On 12/13 Initiated 
HBOT 2 ATA 30 min 
once daily for 4 
sessions
12/16 12/17 12/21 1/19 1/27 2/10 3/17 8/15
BUN 
(9.0-29.0)
42.5 29.1 27.4 37.0 31.7 17.6 14.3 19.1
Cr
(0.4-1.4)
1.9 1.7 2.9 2.3 2.7 1.7 1.4 2.5
Phos
(1.9-5.0)
5.0 4.4 4.3 4.3 3.7 3.2 3.8 3.2
January 19, 2017 




When air cannot move through – needed tracheostomy to 
survive….
Our patient on presentation
PRE
Post first HBOT tx
Post first HBOT tx
Breathing through mouth and nose now
DAY 1 
